
Coherus Oncology, Inc.
Coherus Oncology, Inc. (CHRS)
웹사이트주가
시가총액
다음 일정2027년 상반기 예상Casdozokitug + toripalimab + bevacizumab — randomized first-line uHCC · Phase 2 data회사 보도자료 ↗
현금
차트 및 이벤트
핵심 임상
PreINDP1P2P3FilingApproved
PreINDP2P3FilingApproved
임상 진행
예정 임상 일정
PreINDP1P2P3FilingApproved
PreINDP2P3FilingApproved
그 외 파이프라인
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
승인/상업화
Approved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
과거 이력 · 중단/보류
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
자금 현황
주식 보유 현황·기관투자자
| 상태 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|